Windlas Biotech Ltd appoints Hitesh Windlass Chairman as Ashok Kumar Windlass steps down from director roles
- Hitesh Windlass’s appointment and Ashok Kumar Windlass’s resignation as whole-time director and director took effect November 5, 2026.
- Ashok Kumar Windlass will become Founder President and senior management personnel from November 6, subject to shareholder approval.
- Q2 FY27 revenue was ₹263.91 crore, up 18.7% year on year; net profit was ₹18.05 crore, up 1.4%.
- The auditor’s limited-review conclusion was unmodified, with no material misstatement noted.